InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（17 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
17
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Wilson Mark Andrew, Directeur Juridique. Director active across 2 companies, notably NEKTAR THERAPEUTICS. Aggregated, 22 filings have been recorded. Split: 0 buy · 17 sells. Total volume traded: €253k. History available since 17 May 2021. The latest transaction was filed on 21 November 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wilson Mark Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
1,903 股0Common StockSEC:0001193125-25-297852:0
676 股@ US$26.59100.0% 占其流量Common StockSEC:0000950170-25-110774:0
9,996 股@ US$0.671.8% 占其流量Common StockSEC:0000950170-25-075977:0
11,040 股@ US$1.013.3% 占其流量Common StockSEC:0000950170-25-025040:0
33,402 股@ US$0.908.9% 占其流量Common StockSEC:0000950170-24-140591:0
165,938 股0Common StockSEC:0000950170-24-137544:0
6,407 股@ US$1.011.9% 占其流量Common StockSEC:0000950170-24-129462:0
5,651 股@ US$1.282.0% 占其流量Common StockSEC:0000950170-24-099353:0
6,260 股@ US$1.753.1% 占其流量Common StockSEC:0000950170-24-062644:0
7,606 股@ US$0.681.5% 占其流量Common StockSEC:0000950170-24-019044:0
7,179 股@ US$0.491.0% 占其流量Common StockSEC:0001209191-23-056183:0
7,221 股@ US$0.781.6% 占其流量Common StockSEC:0001209191-23-046461:0
7,543 股@ US$0.721.5% 占其流量Common StockSEC:0001209191-23-030447:0
8,275 股@ US$3.007.2% 占其流量Common StockSEC:0001209191-23-010954:0
8,690 股@ US$3.579.2% 占其流量Common StockSEC:0001209191-22-057967:0
165,938 股0Common StockSEC:0001209191-22-046488:0
3,136 股@ US$3.950.0005% mcap6.4% 占其流量Common StockSEC:0001209191-22-029904:0
3,661 股@ US$10.950.0015% mcap19.1% 占其流量Common StockSEC:0001209191-22-011441:0
37,800 股0Common StockSEC:0001209191-21-070695:0
20,100 股0Common StockSEC:0001209191-21-065225:0
1,910 股@ US$13.839.4% 占其流量Common StockSEC:0001209191-21-052393:0
1,917 股@ US$18.3012.1% 占其流量Common StockSEC:0001209191-21-034190:0
22 条申报中的 22 条
About Wilson Mark Andrew
Wilson Mark Andrew is Chief Legal Officer. He has filed 22 filings in total, and across the 22 sampled filings the transactions are sales, with EUR 0 of purchases and EUR 253434 of sales between 2021-05-19 and 2025-11-25 at NEKTAR THERAPEUTICS.
